nature.com search

Loading Filters

Showing 1–26 of 26 results

Loading Filters

Research | 24 July 2017
Stationary waves and slowly moving features in the night upper clouds of Venus
- J. Peralta
- , R. Hueso
- , A. Sánchez-Lavega
- , Y. J. Lee
- , A. García Muñoz
- , T. Kouyama
- , H. Sagawa
- , T. M. Sato
- , G. Piccioni
- , S. Tellmann
- , T. Imamura
- & T. Satoh
Nature Astronomy 1 , 1–5

Rights & permissionsfor article Stationary waves and slowly moving features in the night upper clouds of Venus . Opens in a new window.
12 January 2017 | Open
Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer
- T Ioka
- , Y Komatsu
- , N Mizuno
- , A Tsuji
- , S Ohkawa
- , M Tanaka
- , H Iguchi
- , A Ishiguro
- , M Kitano
- , T Satoh
- , T Yamaguchi
- , K Takeda
- , M Kida
- , K Eguchi
- , T Ito
- , M Munakata
- , T Itoi
- , J Furuse
- , C Hamada
- & Y Sakata
British Journal of Cancer 116 , 464–471

Rights & permissionsfor article Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer . Opens in a new window.
15 August 2013 | Open
Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas
- A Akiyama-Abe
- , T Minaguchi
- , Y Nakamura
- , H Michikami
- , A Shikama
- , S Nakao
- , M Sakurai
- , H Ochi
- , M Onuki
- , K Matsumoto
- , T Satoh
- , A Oki
- & H Yoshikawa
British Journal of Cancer 109 , 1703–1710

Rights & permissionsfor article Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas . Opens in a new window.
3 September 2013 | Open
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
- M Takano
- , H Ochi
- , Y Takei
- , M Miyamoto
- , Y Hasumi
- , Y Kaneta
- , K Nakamura
- , A Kurosaki
- , T Satoh
- , H Fujiwara
- , S Nagao
- , K Furuya
- , H Yokota
- , K Ito
- , T Minegishi
- , H Yoshikawa
- , K Fujiwara
- & M Suzuki
British Journal of Cancer 109 , 1760–1765

Rights & permissionsfor article Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)? . Opens in a new window.
Research | 3 March 2011
On-demand use of erectile aids in men with preoperative erectile dysfunction treated by whole gland prostate cryoablation
- M Kimura
- , C F Donatucci
- , M Tsivian
- , J R Caso
- , D M Moreira
- , V Mouraviev
- , T Satoh
- , S Baba
- & T J Polascik
International Journal of Impotence Research 23 , 49–55

Rights & permissionsfor article On-demand use of erectile aids in men with preoperative erectile dysfunction treated by whole gland prostate cryoablation . Opens in a new window.
Research | 17 February 2006
Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer
- K Naruishi
- , T L Timme
- , N Kusaka
- , T Fujita
- , G Yang
- , A Goltsov
- , T Satoh
- , X Ji
- , W Tian
- , E Abdelfattah
- , T Men
- , M Watanabe
- , K Tabata
- & T C Thompson
Cancer Gene Therapy 13 , 658–663

Rights & permissionsfor article Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer . Opens in a new window.
9 January 2007 | Open
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer
- K Uno
- , S Homma
- , T Satoh
- , K Nakanishi
- , D Abe
- , K Matsumoto
- , A Oki
- , H Tsunoda
- , I Yamaguchi
- , T Nagasawa
- , H Yoshikawa
- & K Aonuma
British Journal of Cancer 96 , 290–295

Rights & permissionsfor article Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer . Opens in a new window.
19 February 2008 | Open
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)
- K Tamura
- , I Okamoto
- , T Kashii
- , S Negoro
- , T Hirashima
- , S Kudoh
- , Y Ichinose
- , N Ebi
- , K Shibata
- , T Nishimura
- , N Katakami
- , T Sawa
- , E Shimizu
- , J Fukuoka
- , T Satoh
- & M Fukuoka
British Journal of Cancer 98 , 907–914

Rights & permissionsfor article Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403) . Opens in a new window.
Research | 8 April 2008
Distress and social dysfunction following prostate cancer treatment: a longitudinal cross-cultural comparison of Japanese and American men
- S Namiki
- , L Kwan
- , M Kagawa-Singer
- , A Terai
- , T Satoh
- , S Baba
- , Y Arai
- & M S Litwin
Prostate Cancer and Prostatic Diseases 12 , 67–71

Rights & permissionsfor article Distress and social dysfunction following prostate cancer treatment: a longitudinal cross-cultural comparison of Japanese and American men . Opens in a new window.
5 February 2008 | Open
Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status
- Y Akashi
- , I Okamoto
- , T Iwasa
- , T Yoshida
- , M Suzuki
- , E Hatashita
- , Y Yamada
- , T Satoh
- , M Fukuoka
- , K Ono
- & K Nakagawa
British Journal of Cancer 98 , 749–755

Rights & permissionsfor article Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status . Opens in a new window.
Research | 23 December 2008
Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer
- K Tabata
- , M Watanabe
- , K Naruishi
- , K Edamura
- , T Satoh
- , G Yang
- , E Abdel Fattah
- , J Wang
- , A Goltsov
- , D Floryk
- , S D Soni
- , D Kadmon
- & T C Thompson
Prostate Cancer and Prostatic Diseases 12 , 301–309

Rights & permissionsfor article Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer . Opens in a new window.
Research | 29 July 2005
Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model
- T Saika
- , N Kusaka
- , V Mouraviev
- , T Satoh
- , H Kumon
- , T L Timme
- & T C Thompson
Cancer Gene Therapy 13 , 91–98

Rights & permissionsfor article Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model . Opens in a new window.
Research | 14 December 2005
Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects
- R Araki
- , C Maruyama
- , S Igarashi
- , M Yoshida
- , T Maruyama
- , T Satoh
- , M Yoshida
- & K Umegaki
European Journal of Clinical Nutrition 60 , 573–579

Rights & permissionsfor article Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects . Opens in a new window.
9 September 2008 | Open
Silent venous thromboembolism before treatment in endometrial cancer and the risk factors
- T Satoh
- , K Matsumoto
- , K Uno
- , M Sakurai
- , S Okada
- , M Onuki
- , T Minaguchi
- , Y O Tanaka
- , S Homma
- , A Oki
- & H Yoshikawa
British Journal of Cancer 99 , 1034–1039

Rights & permissionsfor article Silent venous thromboembolism before treatment in endometrial cancer and the risk factors . Opens in a new window.
Research | 20 April 2004 | Open
Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer
- T Kurata
- , K Tamura
- , N Yamamoto
- , T Nogami
- , T Satoh
- , H Kaneda
- , K Nakagawa
- & M Fukuoka
British Journal of Cancer 90 , 2092–2096

Rights & permissionsfor article Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer . Opens in a new window.
4 March 2008 | Open
Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer
- Y Yamada
- , M Tahara
- , T Miya
- , T Satoh
- , K Shirao
- , Y Shimada
- , A Ohtsu
- , Y Sasaki
- & Y Tanigawara
British Journal of Cancer 98 , 1034–1038

Rights & permissionsfor article Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer . Opens in a new window.
12 July 2010
Thoracoscopic surgery using local and epidural anesthesia for intractable pneumothorax after BMT
- H Shigematsu
- , A Andou
- , K Matsuo
- , T Satoh
- & R Higashi
Bone Marrow Transplantation 46 , 472–473

Rights & permissionsfor article Thoracoscopic surgery using local and epidural anesthesia for intractable pneumothorax after BMT . Opens in a new window.
12 August 2004
In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity
- K Sumi
- , H Yokozeki
- , M-H Wu
- , T Satoh
- , Y Kaneda
- , K Takeda
- , S Akira
- & K Nishioka
Gene Therapy 11 , 1763–1771

Rights & permissionsfor article In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity . Opens in a new window.
Research | 1 April 1986
²⁰¹T1 to ⁶⁷Ga uptake ratio as an indicator for predicting tumour doubling time in human pulmonary neoplasms
- T Togawa
- , T Satoh
- , K Hoshi
- , K Haneda
- , H Yonemoto
- & K Kimura
British Journal of Cancer 53 , 557–560

Rights & permissionsfor article 201T1 to 67Ga uptake ratio as an indicator for predicting tumour doubling time in human pulmonary neoplasms . Opens in a new window.
1 May 2007 | Open
The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo
- Y Akashi
- , I Okamoto
- , M Suzuki
- , K Tamura
- , T Iwasa
- , S Hisada
- , T Satoh
- , K Nakagawa
- , K Ono
- & M Fukuoka
British Journal of Cancer 96 , 1532–1539

Rights & permissionsfor article The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo . Opens in a new window.
25 September 2007 | Open
High incidence of silent venous thromboembolism before treatment in ovarian cancer
- T Satoh
- , A Oki
- , K Uno
- , M Sakurai
- , H Ochi
- , S Okada
- , R Minami
- , K Matsumoto
- , Y O Tanaka
- , H Tsunoda
- , S Homma
- & H Yoshikawa
British Journal of Cancer 97 , 1053–1057

Rights & permissionsfor article High incidence of silent venous thromboembolism before treatment in ovarian cancer . Opens in a new window.
Research | 23 May 2013 | Open
NLRP3 activation induces ASC-dependent programmed necrotic cell death, which leads to neutrophilic inflammation
- T Satoh
- , N Kambe
- & H Matsue
Cell Death & Disease 4 , e644–e644

Rights & permissionsfor article NLRP3 activation induces ASC-dependent programmed necrotic cell death, which leads to neutrophilic inflammation . Opens in a new window.
Research | 21 April 2011
Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model
- K Tabata
- , S Kurosaka
- , M Watanabe
- , K Edamura
- , T Satoh
- , G Yang
- , E Abdelfattah
- , J Wang
- , A Goltsov
- , D Floryk
- & T C Thompson
Gene Therapy 18 , 969–978

Rights & permissionsfor article Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model . Opens in a new window.
8 January 2004
Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma
- M-H Wu
- , H Yokozeki
- , S Takagawa
- , T Yamamoto
- , T Satoh
- , Y Kaneda
- , I Katayama
- & K Nishioka
Gene Therapy 11 , 170–180

Rights & permissionsfor article Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma . Opens in a new window.
27 August 2009
Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation
- R Ono
- , H Kumagai
- , H Nakajima
- , A Hishiya
- , T Taki
- , K Horikawa
- , K Takatsu
- , T Satoh
- , Y Hayashi
- , T Kitamura
- & T Nosaka
Leukemia 23 , 2197–2209

Rights & permissionsfor article Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation . Opens in a new window.
12 August 2004
In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model
- H Yokozeki
- , M-H Wu
- , K Sumi
- , S Awad
- , T Satoh
- , I Katayama
- , K Takeda
- , S Akira
- , Y Kaneda
- & K Nishioka
Gene Therapy 11 , 1753–1762

Rights & permissionsfor article In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model . Opens in a new window.

Refine your results by…

Filters

Filter By:

Stationary waves and slowly moving features in the night upper clouds of Venus

Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer

Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas

Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?

On-demand use of erectile aids in men with preoperative erectile dysfunction treated by whole gland prostate cryoablation

Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer

Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

Distress and social dysfunction following prostate cancer treatment: a longitudinal cross-cultural comparison of Japanese and American men

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status

Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model

Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects

Silent venous thromboembolism before treatment in endometrial cancer and the risk factors

Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer

Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer

Thoracoscopic surgery using local and epidural anesthesia for intractable pneumothorax after BMT

In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity

²⁰¹T1 to ⁶⁷Ga uptake ratio as an indicator for predicting tumour doubling time in human pulmonary neoplasms

The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo

High incidence of silent venous thromboembolism before treatment in ovarian cancer

NLRP3 activation induces ASC-dependent programmed necrotic cell death, which leads to neutrophilic inflammation

Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model

Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma

Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation

In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters